CVE-2015-1012
Hospira has developed a new version of the PCS Infusion System, version 7.0 that addresses the identified vulnerabilities.
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.77%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Wireless keys are stored in plain text on version 5 of the Hospira LifeCare PCA Infusion System. According to Hospira, version 3 of the LifeCare PCA Infusion System is not indicated for wireless use, is not shipped with wireless capabilities, and should not be modified to be used in a wireless capacity in a clinical setting. Hospira has developed a new version of the PCS Infusion System, version 7.0 that addresses the identified vulnerabilities. Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access.
- CVSS 3.0
- 7.5 HIGHCVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
- EPSS
- 0.77% probability · 54th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-312, CWE-200
- Affected
- pfizer/lifecare pca infusion system firmware
- Source
- ics-cert@hq.dhs.gov
References
- https://ics-cert.us-cert.gov/advisories/ICSA-15-125-01Mitigation, Third Party Advisory, US Government Resource
- https://ics-cert.us-cert.gov/advisories/ICSA-15-125-01Mitigation, Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.